🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#INAVO120 👩🏼 w/ 1) PI3 mutation AND 2)relapse within 12 months of adj ET Fulvestrant + palbo +/- inavolisib: PFS improved 7.3 to 15.0 mo Time to chemo prolonged HR 0.54 AEs include: BG 🍬, diarrhea 💩, rash, and stomatitis 😫...but discontinuations very rare #ASCO24 #bcsm

So, the 3 drug combo is really a 7 drug combo? I think it is safe to say we have farther to go to get from “Comfort to Cure” #ASCO24

One of the most important points I have heard at #ASCO24 so far Jill Feldman 🚫 safety is not tolerability ❤️‍🩹low grade side effects matter Julia Maués Dr. Kelly Shanahan

Thank you ASCO for fostering mentor-mentee relationships across countries! Ishka Que taught me so much about the care delivery I take for granted practicing in a well resourced country!

Check out Journal of Clinical Oncology Podcast: "EAZ171: Predictors of TIPN in Black women with #BreastCancer" w/ Dr. Shannon Westin, MD, MPH, FASCO & Dr. Bryan Schneider. EAZ171 was presented at the #ASCO24 Annual Meeting. Tarah Ballinger, MD @NCIprevention #NCORP Susan G. Komen Vera Bradley Foundation jcopodcast.libsyn.com/eaz171-predict…

🚨Docetaxel chemotherapy causes less peripheral neuropathy than paclitaxel chemotherapy for Black people with early-stage breast cancer Read the lay summary, read the manuscript. So important. #ASCO24 #CIPN Tarah Ballinger, MD OncoAlert

Thank you Susan G. Komen for your support!!

Very grateful for the mentorship and sponsorship I have experienced in ECOG-ACRIN Cancer Research Group thanks to Angie DeMichele, MD, MSCE, FASCO Antonio Wolff, MD (#HealthPolicyIsEconomicPolicy) Lynne I Wagner PhD , providing me the opportunity to disseminate EAZ171 today at #ASCO24 📸: Yara Abdou, MD, MSCR

Congrats to wonderful colleague and leader Nabil Adra

Here are lay summaries on some of the top research presented at #ASCO24. Each summary includes: 👉Who does this study affect? 👉What did this study find? 👉What does this mean for patients? Thank you, ASCO, for your efforts to help the lay community understand all the

Reshma Jagsi, MD, DPhil, and Tarah J. Ballinger, MD, on Early-Stage Breast Cancer in Black Women: Docetaxel and Peripheral Neuropathy ascopost.com/videos/2024-as… #bcsm #breastcancer #oncology #healthequity Reshma Jagsi Winship Cancer Institute of Emory University Emory School of Medicine IU Simon Comprehensive Cancer Center Tarah Ballinger, MD

Congratulations to Nabil Adra for leading the IU School of Medicine IU School of Medicine Department of Medicine Division of Hematology-Oncology 2024 ASCO Review. Thanks to our incredible faculty speakers who made it an informative and entertaining day!

Tune in NOW for Breast Cancer Breakthroughs! Practice-changing advancements in #breastcancer were just announced @ #ASCO24. Komen grantees Tarah Ballinger, MD & Dr. Pedram Razavi explain how these findings are personalizing treatment. Click here to watch: bit.ly/3X1yPW0

Cancer survivorship care IS cancer care. Every bit of clinical work and research done to support survivors is relevant to the cancer care plan and should be delivered in tandem with medical therapies through the cancer continuum, and with primary care follow-up beyond. From

📢 New faculty opportunity in the Division of Breast Surgery! ❗Come join the team at Indiana University School of Medicine in the Division of Breast Surgery as Assistant/Associate/Professor of Clinical Surgery - Breast Surgeon. We are seeking a fellowship-trained breast surgeon

Check out the recently published protocol for the randomized #EMBody trial looking at exercise as part of survivorship care in #MetastaticBreastCancer. 🔓pubmed.ncbi.nlm.nih.gov/39267010/ ✍️ #JenniferLigibel Niraj Shah Dr. Kelly Shanahan Lesley Kailani Glenn Tarah Ballinger, MD #MBC #BreastCancer

Thank you Susan G. Komen for supporting our work advancing survivorship for MBC

I’ll just say this. We do what we know. I am an oncologist, & what oncologists do not do is run from human suffering or give up. ❤️‍🩹 #Election2024 #MedTwitter

Excellent discussion of the PRO-B study and ePROs in MBC by my collaborator and friend Gabrielle 👸🏻 This is feasible and helps patients, so let’s get it done! Excited to continue our work implementing IU Simon Comprehensive Cancer Center IU Health Carevīve #SABCS24 #survonc

Congratulations to Dani Halsey - our lead exercise physiologist in the IU cancer exercise MOVE program - she is a finalist for ⁦American College of Sports Medicine⁩ professional of the year! 🙌🏼 ⁦IU Health Foundation⁩ ⁦IU Simon Comprehensive Cancer Center⁩ acsm.org/certification/…